While no FDA-approved tapering protocol exists, structured approaches involving alternative therapies, lifestyle intensification, and close monitoring optimize outcomes
Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA (1999)
Pro Tip Before finalizing the code, take a quick look at the full visit
The current study also revealed that 24 (82.8%) of our patients had dyslipidemia, and glutathione treatment reduced triglyceride and NEFA levels significantly
And let's be honest, this new format brings a wave of questions
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 111,21 per year only 9,27 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Subjects References Alzheimers Association